Institutional investors hold a majority ownership of VTRS through the 76.47% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended June 2019, these large investors purchased a net $1.6 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 6.8 Million shares of Viatris Inc
ALLSPRING GLOBAL INVESTMENTS LLC Bought 4.2 Million shares of Viatris Inc
PACER ADVISORS, INC. Bought 3.5 Million shares of Viatris Inc